Effect of Zingiber officinale R. Rhizomes (ginger) on pain relief in primary dysmenorrhea: A placebo randomized trial

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Rahnama, Parvin ^a   Montazeri, Ali ^b   Huseini, Hassan F ^b   Kianbakht, Saeed ^b   Naseri, Mohsen ^a  

^a SHAHED UNIVERSITY   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GINGER EXTRACT; PLACEBO;

ADULT; ANALGESIC ACTIVITY; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DYSMENORRHEA; FEMALE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHIZOME; VISUAL ANALOG SCALE;

ADULT; DOUBLE-BLIND METHOD; DYSMENORRHEA; FEMALE; GINGER; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; RHIZOME; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84863600256     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-92     Document Type: Article

References (34)

1. Dawood MY. Primary dysmenorrhea: Advances in pathogenesis and management. Obstet Gynecol 2006, 108:428-441. 10.1097/01.AOG.0000230214.26638.0c, 16880317.
2. Milsom I, Minic M, Dawood MY, Akin MD, Spann J, Niland NF, Squire R. Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies. Clin Ther 2002, 24:1384. 10.1016/S0149-2918(02)80043-1, 12380631.
3. Rosenwaks Z, Seegar-Jones G. Menstrual pain: its origin and pathogenesis. J Reprod Med 1980, 25:207-12.
4. Bieglmayer C, Hofer G, Kainz C, Reinthaller A, Kopp B, Janisch H. Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. Gynecol Endocrinol 1995, 9:307-312. 10.3109/09513599509160464, 8629459.
5. Edwards JE, Moore AR, Mcquay HJ. Rofecoxib for dysmenorroea: meta-analysis using individual patient data. BMC Womens Health 2004, 4:5. 10.1186/1472-6874-4-5, 493273, 15265230.
6. Daniels SE, Torri S, Desjardins PJ. Valdecoxib for Treatment of Primary Dysmenorrhea, A Randomized, Double-blind Comparison with Placebo and Naproxen. J Gen Intern Med 2005, 20:62-67. 10.1111/j.1525-1497.2004.30052.x, 1490036, 15693930.
7. Zhu X, Proctor M, Bensoussan A, Smith CA, Wu E. Chinese herbal medicine for primary dysmenorrhoea. Cochrane Database Syst Rev 2007, 17. CD005288.
8. Proctor ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2001, CD002124.
9. Kikuzaki H, Nakatani N. Cyclic diarylheptanoids from rhizomes ofZingiber officinale. Phytochemistry 1996, 43:273-277.
10. Schulick P. Ginger, common spice and wonder drug 1996, Brattleboro (VT): Herbal Free Press Ltd, 3.
11. Lee SH, Cekanova M, Baek SJ. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog 2008, 47:197-208. 10.1002/mc.20374, 2430145, 18058799.
12. Pongrojpaw D, Somprasit C, Chanthasenanont A. A randomized comparison of ginger and dimenhydrinate in the treatment of nausea and vomiting in pregnancy. J Med Assoc Thai 2007, 90:1703-1709.
13. Ryan JL, Heckler CE, Roscoe JA, Dakhil SR, Kirshner J, Flynn PJ, Hickok JT, Morrow GR. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer 2011, 20:1479-1489. 3361530, 21818642.
14. Chaiyakunapruk N, Kitikannakorn N, Nathisuwan S, Leeprakobboon K, Leelasettagool C. The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis. Am J Obstet Gynecol 2006, 194:95-99. 10.1016/j.ajog.2005.06.046, 16389016.
15. Haghighi M, Khalvat A, Toliat T, Jallaei S. Comparing the effects of ginger (zingiber officinale) extract and ibuprofen on patients with osteoarthritis. Arch Iran Med 2005, 8:267-271.
16. Mustafa T, Srivastava KC, Jensen KB. Drug development: report 9. Pharmacology of ginger, Zingiber officinale. J Drug Dev 1993, 6:25-89.
17. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sandawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingeroles and diarylhepatanoids. Chem Pharm Bull (Tokyo) 1992, 40:187-191.
18. Ozgoli G, Goli M, Moattar F. Comparison of Effects of Ginger, Mefenamic Acid, and Ibuprofen on Pain in Women with Primary Dysmenorrhea. J Altern Complement Med 2009, 15:129-132. 10.1089/acm.2008.0311, 19216660.
19. Grzanna R, Lindmark L, Frondoza CG. Ginger-An herbal medicinal product with broad anti-inflammatory actions. J Med Food 2005, 8:125-132. 10.1089/jmf.2005.8.125, 16117603.
20. Paula JAH. Benign diseases of female reproductive tract 2007, 446. Philadelphia: Berek and Novak's Gynecology, Lippincott William and Wilkins: Wolterrs Kluwer business, 14.
21. Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrheal. Am J Obstet Gynecol 1982, 144:655-660.
22. Carlsson AM. Assessment of chronic pain. I. Aspects of the Reliability and Validity of the Visual Analogue Scale. Pain 1983, 16:87-101. 10.1016/0304-3959(83)90088-X, 6602967.
23. Lee JS, Hobden E, Stiell IG, Wells GA. Clinically important change in the visual analog scale after adequate pain control. Acad Emerg Med 2003, 10:1128-1130. 10.1111/j.1553-2712.2003.tb00586.x, 14525749.
24. Dawood MY. Efficacy and safety of piroxicam-B-cyclodextrin (PBCD, Brexidol). Comparison studies with ibuprofen, naproxen sodium and placebo in the relief of moderate to severe abdominal pain associated with primary dysmenorrhea. The Brexidol Study Group. Today's Therapeutic Trends 1999, 17:273-288.
25. Zhang WY, Li Wan Po A. Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review. Br J Obstet Gynaecol 1998, 105:780-9. 10.1111/j.1471-0528.1998.tb10210.x, 9692420.
26. Morrison JC, Ling FW, Forman EK, Bates GW, Blake PG, Vecchin TJ, Linden CV, O'Connell MJ. Analgesic efficacy of ibuprofen for treatment of primary dysmenorrhea. South Med J 1980, 73:999-1002. 10.1097/00007611-198008000-00014, 6996107.
27. Campbell MA, McGrath PJ. Use of medication by adolescents for the management of menstrual discomfort. Arch Pediatr Adolesc Med 151:905-912.
28. Traversa G, Walker A, Ippolito F, Caffari B, Capurso L, Dezi A, Koch M, Maggini M, Alegiani S, Raschetti R. Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology 1995, 6:49-54. 10.1097/00001648-199501000-00010, 7888445.
29. Higuchi K, Umegaki E, Watanabe T, Yoda Y, Morita E, Murano M, Tokioka S, Arakawa T. Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol 2009, 44:879-888. 10.1007/s00535-009-0102-2, 19568687.
30. Weidner MS, Sigwart K. Investigation of the teratogenic potential of Zingiber officinale extract in the rat. Reprod Tocicol 2000, 15:75-80.
31. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility 2005, Philadelphia: Lippincott Williams and Wilkins, 7.
32. Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinaleRoscoe): a review of recent research. Food Chem Toxicol 2008, 46:409-420. 10.1016/j.fct.2007.09.085, 17950516.
33. Kim JK, Kim Y, Na KM, Surh YJ, Kim TY. [6]-Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo. Free Radic Res 2007, 41:603-614. 10.1080/10715760701209896, 17454143.
34. Rahnama P, Falah Hossini H, Mohammadi K, Modares M, Khajavi Shojaei K, Askari M, Mozayani P. The effects of Zingiber Officional R on primary dysmenorrhea. J Med Plants 2010, 9:81-86.